Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2005
09/28/2005EP1580276A1 Packaging cell system for eb virus vector
09/28/2005EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV)
09/28/2005EP1580266A1 Screening method
09/28/2005EP1579221A2 Uses of hmgb, hmgn, hmga proteins
09/28/2005EP1579006A2 Modulation of jagged 1 expression
09/28/2005EP1579001A2 Materials and methods for prevention and treatment of rna viral diseases
09/28/2005EP1578974A2 Wound healing method and kits
09/28/2005EP1578942A2 ANTISENSE MODULATION OF mitoNEET EXPRESSION
09/28/2005EP1578939A2 Translational control by small, non-translatable rnas
09/28/2005EP1578926A2 Novel prostate tumor-specific promoter
09/28/2005EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/28/2005EP1578921A2 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
09/28/2005EP1578919A2 Endogenous retrovirus up-regulated in prostate cancer
09/28/2005EP1578916A2 Human ras interacting protein
09/28/2005EP1578915A2 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578912A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/28/2005EP1578901A2 Linear dna fragments for gene expression
09/28/2005EP1578897A2 Process for inducing functional tolerance to gene transfer products
09/28/2005EP1578802A1 Dna/rna transduction technology and its clinical and basic applications
09/28/2005EP1578761A2 Structural motifs and oligomeric compounds and their use in gene modulation
09/28/2005EP1578451A2 Treating carcinoid neoplasms with therapeuthic viruses
09/28/2005EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer
09/28/2005EP1578366A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
09/28/2005EP1578358A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
09/28/2005EP1578252A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
09/28/2005EP1578196A2 Mda-7 and free radicals in the treatment of cancer
09/28/2005EP1465489A4 Methods of expressing lim mineralization protein in non-osseous cells
09/28/2005EP1356277A4 Method for altering cell fate
09/28/2005EP0991763B1 Modified adenoviral fiber and target adenoviruses
09/28/2005EP0977871B1 Neurotrypsin
09/28/2005EP0912743B1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
09/28/2005CN1675363A T-cell epitopes in staphylococcal enterotoxin B
09/28/2005CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof
09/28/2005CN1675353A Substances for preventing and treating autoimmune diseases
09/28/2005CN1674935A Biofunctional CpG or oligo-/polynucleotide and toxin or enterotoxin containing composition
09/28/2005CN1674923A Non-polymeric hematopoeitic cell clots for delivery of active agents
09/28/2005CN1673381A Gene gun
09/28/2005CN1673380A Phosphoric acid receptor protein gene glandular related viral vector and construction and application
09/28/2005CN1673372A A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof
09/28/2005CN1673371A A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof
09/28/2005CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion
09/28/2005CN1220775C ST13 gene 5' terminal promotion function zone sequence and use thereof
09/27/2005US6949623 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells
09/27/2005US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP)
09/27/2005US6949365 Gonadotropin-releasing hormone (GnRH-III); for controlling the gonadal development and spawning, maturation, and reproduction of fish
09/27/2005US6949361 Polynucleotide
09/27/2005US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it
09/27/2005US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates
09/27/2005US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
09/27/2005US6949087 Apparatus with weeping tip and method of use
09/27/2005CA2250682C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/22/2005WO2005087931A1 Modified oncolytic viruses
09/22/2005WO2005087926A2 Multiple promoter expression cassettes for simultaneous delivery of rnai agents
09/22/2005WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance
09/22/2005WO2005087808A2 Growth factor binding constructs materials and methods
09/22/2005WO2005087792A2 Materials and methods relating to the treatment of glioblastomas
09/22/2005WO2005087269A1 Method of inhibiting tumor proliferation
09/22/2005WO2005087249A1 Protease inhibitor and preventives or remedies for diseases
09/22/2005WO2005086922A2 Oncolytic adenovirus armed with therapeutic genes
09/22/2005WO2005086896A2 Delivery vectors for short interfering rna, micro-rna and antisense rna
09/22/2005WO2005086825A2 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
09/22/2005WO2005086804A2 Modulation of ace2 expression
09/22/2005WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery
09/22/2005WO2005086695A2 Intracellular interleukin-1 receptor antagonist and uses thereof
09/22/2005WO2005086684A2 Method for modulating, regulating and/or stabilizing angiogenesis
09/22/2005WO2005073384A3 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
09/22/2005WO2005056020B1 Nf-kb oligonucleotide decoy molecules
09/22/2005WO2005052143A3 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses
09/22/2005WO2005046594A3 Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders
09/22/2005WO2004047741A3 Modulation of iap-like expression
09/22/2005WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof
09/22/2005US20050210537 Using cardiomyocyte nuclear transplantion in generation of hybrid cells
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005US20050209184 Oligodeoxynucleotide and its use to induce an immune response
09/22/2005US20050209183 Immunosuppression of expression of proinflammatory cytokines and chemokines (IL-6 and IL-8) in skin cells
09/22/2005US20050209182 Inhibits bacterial subtilisn type serine protease CylA activity; siRNA, antisense, and enzymatic nucleic acid molecules that can modulate the expression of CylA genes
09/22/2005US20050209181 Compositions and methods for diagnosing and treating mental disorders
09/22/2005US20050209180 RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)
09/22/2005US20050209179 chemically synthesized double stranded siNA that directs cleavage of an amyloid precursor protein (APP) RNA
09/22/2005US20050209178 Methods and compositions for the treatment of obesity
09/22/2005US20050209177 Combined use of genes that block oncogenic cell signalling pathways and chemotherapeutic and or radiotherapeutic agents
09/22/2005US20050209141 Mast cell-derived renin
09/22/2005US20050209140 Methods of controlling axonal growth
09/22/2005US20050208660 Infecting a eukaryotic cell with a vactor system having DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct
09/22/2005US20050208658 RNA interference mediated inhibition of 11beta hydroxysteriod dehydrogenase-1 (11beta HSD-1) gene expression
09/22/2005US20050208657 Delivery of functional protein sequences by translocating polypeptides
09/22/2005US20050208622 50 human secreted proteins
09/22/2005US20050208621 Nucleotide sequences coding serine threonine kinase for identifying modulators for prevention and treatment of inflammation, endocrine and nervous system disorders
09/22/2005US20050208618 Nucleotide sequences coding thrombospondin metalloproteinase-like-thrombospondin type 1 (ITGL-TSP) protein for identifying modulators to treat and prevent diabetes, restenosis, alzheimer's, cell proliferative and cardiovascular disorders
09/22/2005US20050208566 Using enzymatic membrane protein as tool in identifying modulators for prevention and treatment of atherosclerotic, inflammatory and cell proliferative disorders
09/22/2005US20050208565 29 human cancer associated proteins
09/22/2005US20050208553 Using nucleotide sequences coding retinoblastoma protein-interacting zinc finger gene (RIZ) as gene therapeutic tools in treatment of cancer; tissue targeted therapy; gene therapy
09/22/2005US20050208552 Corpuscles of Stannius protein, stanniocalcin
09/22/2005US20050208546 Nucleotide sequences coding tumor associated antigens for use as tool in diagnosis, prevention and treatment of cell proliferative disorders
09/22/2005US20050208535 Using retinol binding protein 4 (RBP4)/transthyretin complex formation as tool in identifying modulators of eating and pancreatic disorders
09/22/2005US20050208532 Compositions and their uses directed to signal transducers
09/22/2005US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
09/22/2005US20050208496 Using enhanced interleukin gene expression as diagnostic indicator of respiratory system disorders
1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 870